599 related articles for article (PubMed ID: 10989749)
21. Contribution of the renin-angiotensin and kallikrein-kinin systems to short-term variability of blood pressure in two-kidney, one-clip hypertensive rats.
Ponchon P; Elghozi JL
Eur J Pharmacol; 1996 Feb; 297(1-2):61-70. PubMed ID: 8851167
[TBL] [Abstract][Full Text] [Related]
22. Sympathetic cardiac influence and arterial blood pressure instability.
Formes KJ; Wray DW; O-Yurvati AH; Weiss MS; Shi X
Auton Neurosci; 2005 Mar; 118(1-2):116-24. PubMed ID: 15795185
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
[TBL] [Abstract][Full Text] [Related]
24. Effect of combination of valsartan with benazepril on blood pressure and left ventricular hypertrophy in SHR.
Ke YS; Cao H; Yang T
Acta Pharmacol Sin; 2000 Nov; 21(11):1043-7. PubMed ID: 11501062
[TBL] [Abstract][Full Text] [Related]
25. Importance of the renin-angiotensin system in the regulation of arterial blood pressure in conscious mice and rats.
Cholewa BC; Meister CJ; Mattson DL
Acta Physiol Scand; 2005 Mar; 183(3):309-20. PubMed ID: 15743391
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
Lassila M; Davis BJ; Allen TJ; Burrell LM; Cooper ME; Cao Z
Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675
[TBL] [Abstract][Full Text] [Related]
27. The angiotensin type 1 receptor antagonist valsartan attenuates pathological ventricular hypertrophy induced by hyperhomocysteinemia in rats.
Kassab S; Garadah T; Abu-Hijleh M; Golbahar J; Senok S; Wazir J; Gumaa K
J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):206-11. PubMed ID: 17318789
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Ang II and renal sympathetic nerve influence dopamine-and isoprenaline-induced renal haemodynamic changes in normal Wistar-Kyoto and spontaneously hypertensive rats.
Abdulla MH; Sattar MA; Abdullah NA; Hazim AI; Anand Swarup KR; Rathore HA; Khan MA; Johns EJ
Auton Autacoid Pharmacol; 2008 Oct; 28(4):95-101. PubMed ID: 18778332
[TBL] [Abstract][Full Text] [Related]
29. Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption.
Azizi M; Ménard J; Bissery A; Guyenne TT; Bura-Rivière A; Vaidyanathan S; Camisasca RP
J Am Soc Nephrol; 2004 Dec; 15(12):3126-33. PubMed ID: 15579516
[TBL] [Abstract][Full Text] [Related]
30. Glomerular permeability defect in hypertension is dependent on renin angiotensin system activation.
Candido R; Carraro M; Fior F; Artero ML; Zennaro C; Burrell LM; Davis BJ; Cattin MR; Bardelli M; Faccini L; Carretta R; Fabris B
Am J Hypertens; 2005 Jun; 18(6):844-50. PubMed ID: 15925746
[TBL] [Abstract][Full Text] [Related]
31. Effect of valsartan and captopril in rabbit carotid injury. Possible involvement of bradykinin in the antiproliferative action of the renin-angiotensin blockade.
Feng TC; Ying WY; Hua RJ; Ji YY; de Gasparo M
J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):19-24. PubMed ID: 11881060
[TBL] [Abstract][Full Text] [Related]
32. Differential effect of tetradecythioacetic acid on the renin-angiotensin system and blood pressure in SHR and 2-kidney, 1-clip hypertension.
Bivol LM; Berge RK; Iversen BM
Am J Physiol Renal Physiol; 2007 Sep; 293(3):F839-45. PubMed ID: 17596529
[TBL] [Abstract][Full Text] [Related]
33. [Role of the renin-angiotensin system on the sympathetic response induced by the cold pressor test in humans].
Zavala LE; Cierco M; Gutiérrez A; Garrido MR; Israel A
Invest Clin; 2007 Jun; 48(2):155-65. PubMed ID: 17598639
[TBL] [Abstract][Full Text] [Related]
34. The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers.
Daul A; Hermes U; Schäfers RF; Wenzel R; von Birgelen C; Brodde OE
Int J Clin Pharmacol Ther; 1995 Mar; 33(3):140-8. PubMed ID: 7599912
[TBL] [Abstract][Full Text] [Related]
35. Contribution of humoral systems to the short-term variability of blood pressure after severe hemorrhage.
Ponchon P; Elghozi JL
Am J Physiol; 1997 Jul; 273(1 Pt 2):R58-69. PubMed ID: 9249533
[TBL] [Abstract][Full Text] [Related]
36. The angiotensin II receptor antagonist valsartan inhibits endothelin 1-induced vasoconstriction in the skin microcirculation in humans in vivo: influence of the G-protein beta3 subunit (GNB3) C825T polymorphism.
Mitchell A; Rushentsova U; Siffert W; Philipp T; Wenzel RR
Clin Pharmacol Ther; 2006 Mar; 79(3):274-81. PubMed ID: 16513451
[TBL] [Abstract][Full Text] [Related]
37. Valsartan and the renin-angiotensin-aldosterone system: blood pressure control and beyond.
Dahlöf B
J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2 Suppl):S14-6. PubMed ID: 17199213
[TBL] [Abstract][Full Text] [Related]
38. Involvement of the renin-angiotensin system in endogenous central histamine-induced reversal of critical haemorrhagic hypotension in rats.
Jochem J
J Physiol Pharmacol; 2004 Mar; 55(1 Pt 1):39-55. PubMed ID: 15082866
[TBL] [Abstract][Full Text] [Related]
39. Selective angiotensin receptor antagonism with valsartan decreases arterial stiffness independently of blood pressure lowering in hypertensive patients.
Nakamura T; Fujii S; Hoshino J; Saito Y; Mizuno H; Saito Y; Kurabayashi M
Hypertens Res; 2005 Dec; 28(12):937-43. PubMed ID: 16671331
[TBL] [Abstract][Full Text] [Related]
40. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
Freitas RR; Lopes KL; Carillo BA; Bergamaschi CT; Carmona AK; Casarini DE; Furukawa L; Heimann JC; Campos RR; Dolnikoff MS
Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
